Aktive Positionen von Stephen Goodall
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| FIREBRICK PHARMA LIMITED | Direktor/Vorstandsmitglied | 12.04.2012 | - |
| Geschäftsführer | 12.04.2012 | - | |
| Gründer | 12.04.2012 | - |
Karriereverlauf von Stephen Goodall
Ehemalige bekannte Positionen von Stephen Goodall
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| VIRALYTICS LTD. | Geschäftsführer | 25.10.2009 | 31.08.2011 |
Vapotronics, Inc.
 Vapotronics, Inc. Medical SpecialtiesHealth Technology Vapotronics, Inc. develops inhalation drug products. The company is headquartered in South Brisbane, Australia. | Corporate Officer/Principal | 01.08.1999 | 01.06.2001 |
Statistik
International
| Australien | 4 |
Operativ
| Chief Operating Officer | 2 |
| Director/Board Member | 1 |
| Founder | 1 |
Sektoral
| Health Technology | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| FIREBRICK PHARMA LIMITED | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Viralytics Pty Ltd.
 Viralytics Pty Ltd. BiotechnologyHealth Technology Viralytics Pty Ltd. engages in the development and commercialization of oncolytic immunotherapies that harness the power of certain viruses to infect and kill cancer cells. Its product, CAVATAK, is a genetically unmodified proprietary formulation of the common cold Coxsackievirus Type A21. The company was founded in 1984 and is headquartered in Sydney, Australia. | Health Technology |
Vapotronics, Inc.
Vapotronics, Inc. Medical SpecialtiesHealth Technology Vapotronics, Inc. develops inhalation drug products. The company is headquartered in South Brisbane, Australia. | Health Technology |
- Börse
- Insiders
- Stephen Goodall
- Erfahrung
